Article
TGF-β signaling pathway and breast cancer susceptibility.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology - 1 Jun 2011
Scollen Serena, Luccarini Craig, Baynes Caroline, Driver Kristy, Humphreys Manjeet K, Garcia-Closas Montserrat, Figueroa Jonine, Lissowska Jolanta, Pharoah Paul D, Easton Douglas F, Hesketh Robin, Metcalfe James C, Dunning Alison M
Abstract excerpt
BACKGROUND: TGF-β acts as a suppressor of primary tumor initiation but has been implicated as a promoter of the later malignant stages. Here associations with risk of invasive breast cancer are assessed for single-nucleotide polymorphisms (SNP) tagging 17 genes in the canonical TGF-β ALK5/SMADs 2&3 and ALK1/SMADs 1&5 signaling pathways: LTBP1, LTBP2, LTBP4, TGFB1, TGFB2, TGFB3, TGFBR1(ALK5), ALK1, TGFBR2,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
